Table 2

Binding experiments with [3H]GBC and [3H]P1075 in membranes

[3H]GBC[3H]P1075
GBCP1075P1075GBC
KDnKiAnKDnKiAn
nM nM %B S nM nM %B S
SUR2B2B(Y1206S)3.4 (2.9,3.9)45.6 (3.4,9.3)45  ± 466.5 (6.2,6.8)3245 (162,372)1003
660 (480,910)55  ± 4
Kir6.1/SUR2B(Y1206S)2.5 (2.2,2.9)35.9 (4.7,7.4)73  ± 22-a 36.8 (5.6,8.1)32.7 (1.9,3.7)2-b 59  ± 12-b 6
690 (600,790)27  ± 22-a 360 (230,540)2-b 41  ± 12-b
Kir6.2/SUR2B(Y1206S)2.7 (2.3,3.0)37.1 (6.5,7.8)75  ± 22-a 37.2 (4.4,12.0)34.4 (2.8,6.9)75  ± 34
650 (340,1230)25  ± 22-a 288 (191,437)25  ± 3
SUR2BN.D.N.D.3.3 (2.4,4.6)42400 (1900,3000)1004
Kir6.1/SUR2BN.D.N.D.4.472 (50,105)62  ± 33
2400 (2000,2900)38  ± 3
Kir6.2/SUR2BN.D.N.D.4.450 (21,120)42  ± 33
200 (1000,4000)58  ± 3

K D/K i values are geometric means from n independent experiments; A denotes the amplitudes in percentage of specific binding. Experiments were performed as described in Fig. 5. Experiments on SUR2B are from Hambrock et al. (1998).

    • 2-a  Amplitudes but not pK i values are different from those of curve with SUR2B(Y1206S) alone (P < 0.01, analysis of variance followed by Tukey-Kramer).

    • 2-b  Parameters pooled from experiments with plasmid ratio Kir:SUR = 1:1 and 4:1 (see text).

    • N.D., not determined (see text).